0001213900-24-043594 | 10-Q | XBRL Viewer

Print Document

Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Future Amortization of Intangible Assets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Future Amortization of Intangible Assets [Abstract]
2024 (Remainder of the Year)	$ 130,224
2025	69,328
2026	19,230
2027	16,461
2028	16,461
Thereafter	31,889
Total	$ 283,593	$ 327,001

Intangible Assets, Net (Other than Goodwill) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Intangible Assets, Net (Other than Goodwill) [Abstract]
Amortization expense	$ 43,000	$ 76,000

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,057,577)	$ (1,783,881)
Adjustments to reconcile net loss with cash flows from operations:
Stock-based compensation	722,971	(2,598,592)
Depreciation and amortization expense	43,408	76,017
Amortization of debt discounts and issuance costs	4,115	567,287
Non-cash recruiting fees		492,000
Shares issued in lieu of interest		222,427
Other non-cash interest expense		8,250
Changes in operating assets and liabilities:
Accounts receivable	(237,506)	206,419
Deferred contract costs	(44,368)
Other assets	(59,233)	106,600
Accounts payable and accrued expenses	(495,357)	155,371
Deferred revenue	176,019	(7,449)
Other accrued liabilities		325,000
Adjustments relating to discontinued operations		60,494
Net cash flows from operating activities	(2,947,528)	(2,170,057)
CASH FLOWS FROM FINANCING ACTIVITIES:
Credit facility drawdown, net of issuance costs		543,760
Net cash flows from financing activities		543,760
Effect of Foreign Currencies	(3,359)	(22,505)
Net Change in Cash	(2,950,887)	(1,648,802)
Cash, Beginning of the Period	10,177,099	3,237,106
Cash, Beginning of the Period - Discontinued Operations		2,703
Cash, End of the Period - Discontinued Operations		(3,025)
Cash, End of the Period	7,226,212	1,587,982
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	9,023
Cash paid for income taxes - discontinued operations		$ 1,294

Basis of Presentation

3 Months Ended

Mar. 31, 2024

Basis of Presentation [Abstract]

BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

In the opinion of Management, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for future periods or the full year.

The condensed consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

Going Concern

As of March 31, 2024, the Company had an accumulated deficit of approximately $162.6 million. For the three months ended March 31, 2024, the Company earned revenue from continuing operations of approximately $0.16 million, used approximately $2.9 million to fund its operations, and incurred a net loss of approximately $3.1 million.

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders and noteholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows. In 2024 and 2025, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

Reclassification

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, we reclassified approximately $19,000 in Q1 2023 expenses from research and development expenses to general and administrative expenses.

Net Loss per Common Share

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three months ended March 31, 2024 and 2023 because their effect was antidilutive:

Security	2024		2023

Convertible notes payable		8,277		308,287
Warrants		598,267		153,653
Stock options		1,880,971		993,208
		2,487,515		1,455,148

Revenue Recognition

Verified Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.

For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue.

Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period.

The Company had deferred revenue contract liabilities of approximately $308,000 and $132,000 as of March 31, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of March 31, 2024 are expected to be earned over the next twelve months.

Remaining Performance Obligations

As of March 31, 2024, the Company’s Remaining Performance Obligation (RPO) was $4.03 million, of which $0.31 million is held as deferred revenue and $3.73 million is related to other non-cancellable contracted amounts. The Company expects approximately 40% of the RPO to be recognized as revenue over the next twelve months ending March 31, 2025 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the three months ended March 31, 2024:

	Deferred
	Contract Costs

Carrying Value at December 31, 2023	$	157,300
Additions		5,850
Amortization		(2,432	)
Carrying Value at March 31, 2024	$	160,718

Basis of Presentation (Details) - Schedule of Diluted Loss per Share - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	2,487,515	1,455,148
Convertible Notes Payable [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	8,277	308,287
Warrant [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	598,267	153,653
Stock options [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	1,880,971	993,208

Related Party Transactions

3 Months Ended

Mar. 31, 2024

RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

Board of Directors

On February 15, 2024, Mr. Joe Trelin tendered his resignation as Chairman and a Director of the Company, effective immediately. On February 20, 2024, the board of directors of the Company (the “Board”) accepted his resignation and agreed to vest the unvested portion of an option granted to Mr. Trelin on June 28, 2023, amounting to 6,511 shares.

Commercial Agreements

On June 6, 2023, the Company entered into a services agreement with The Pipeline Group, Inc. (“TPG”). Ken Jisser, a director of the Company, is the founder and CEO of TPG, a technology-enabled services company that aims to deliver business results for companies looking to build a predictable and profitable pipeline. As of March 31, 2024, the Company held a balance of approximately $163,000 in prepaid expenses related to this service agreement.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

Accounts Payable and Accrued Expenses (Details) - Schedule of Accounts Payable and Accrued Expenses - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Accounts Payable and Accrued Expenses [Abstract]
Trade payables	$ 239,376	$ 339,832
Accrued payroll and related obligations	412,965	707,317
Other accrued expenses	253,903	361,816
Total	$ 906,244	$ 1,408,965

Stockholders' Equity

3 Months Ended

Mar. 31, 2024

Stockholders' Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 6 – STOCKHOLDERS’ EQUITY

On June 26, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a one-for-eight (1-for-8) reverse split (the “Reverse Split”) of the shares of the Company’s common stock. The Reverse Split became effective on July 7, 2023. As a result of the Reverse Split, every eight shares of the Company’s issued and outstanding common stock automatically converted into one share of common stock, without any change in the par value per share, and began trading on a post-split basis under the Company’s existing trading symbol, “AUID”, when the market opened on July 10, 2023. The Reverse Split affected all holders of common stock uniformly and did not affect any common stockholder’s percentage ownership interest in the Company, except for de minimis changes as a result of the elimination of fractional shares. A total of 62,816,330 shares of common stock were issued and outstanding immediately prior to the Reverse Split, and 7,874,962 shares of common stock were issued and outstanding immediately after the Reverse Split. No fractional shares were outstanding following the Reverse Split. Any holder who would have received a fractional share of common stock received an additional fraction of a share of common stock to round up their holding to the next whole share. In addition, effective as of the Reverse Split, proportionate adjustments were made to all then-outstanding options and warrants with respect to the number of shares of common stock subject to such options or warrants and the exercise prices thereof, as well as to the conversion price under the remaining Convertible Notes. The impact of this change in capital structure has been retroactively applied to all periods presented herein.

Common Stock

There was no common stock issued during the three months ended March 31, 2024.

During the quarter ended March 31, 2023, the Company issued 68,186 shares of common stock for approximately $222,000 of interest accrued under the Convertible Notes.

Warrants

There was no warrant activity for the three months ended March 31, 2024 and 2023. As of March 31, 2024, there are warrants to acquire 598,267 shares for a weighted average exercise price of $11.89 per share with weighted average remaining life of 3.7 years.

Stock Options

During the three months ended March 31, 2024, the Company granted a total of 100,000 options to certain new employees at exercise prices ranging from $9.05 to $9.61 per share.

During the three months ended March 31, 2024 the Company agreed to accelerate the vesting of 6,511 options for Mr. Joe Trelin under the terms of his resignation with an exercise price of $5.48 per share. These accelerated options would not otherwise have vested prior to termination of service according to their Service conditions. Therefore, the Company recalculated the fair value of these options as of his termination date of February 20, 2024 using the Black Scholes method.

The Company determined the grant date fair value of options granted for the three months ended March 31, 2024, using the Black Scholes Method, as applicable, with the following assumptions:

Expected volatility		123%
Expected term		5 years
Risk free rate		3.80% – 4.03%
Dividend rate		0.00%

Activity related to stock options for the three months ended March 31, 2024 (unaudited), is summarized as follows:

				Weighted		Weighted
				Average		Average		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Shares			Price		Term (Yrs.)		Value

Outstanding at December 31, 2023		1,796,743		$	25.20		6.5	$	3,630,733
Granted		100,000		$	9.38		10.0	$	-
Exercised		-		$	-		-	$	-
Forfeited/cancelled		(15,772	)	$	13.35		4.3	$	-
Outstanding as of March 31, 2024		1,880,971		$	24.23		6.4	$	2,163,663
Exercisable as of March 31, 2024		1,158,568		$	30.57		5.0	$	1,085,676

The following table summarizes stock option information as of March 31, 2024 (unaudited):

			Weighted
			Average
			Contractual
Exercise Price	Outstanding		Term (Yrs.)		Exercisable

$2.64 – $5.00		354,379		8.8		171,103
$5.01 – $10.00		661,189		9.1		224,949
$10.01 – $15.00		43,703		2.7		43,703
$15.01 – $20.00		252,084		1.5		252,084
$20.01 – $121.28		569,616		4.1		466,729
		1,880,971		6.1		1,158,568

During the three months ended March 31, 2024, the Company recognized approximately $0.72 million of stock option-based compensation expense. As of March 31, 2024, there was approximately $2.6 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2027.

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net Loss	$ (3,057,577)	$ (1,783,881)
Foreign currency translation gain (loss)	4,078	(24,066)
Comprehensive loss	$ (3,053,499)	$ (1,807,947)

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

Legal Matters

From time to time the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe that the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

Leases

The Company has no remaining lease agreements as of July 2023.

Rent expense included in general and administrative on the Consolidated Statements of Operations for the three months ended March 31, 2024 was approximately $1,000, compared with $5,000 for the three months ended March 31, 2023.

Stockholders' Equity (Details) - Schedule of Grant Date Fair Value of Options Granted	3 Months Ended
	Mar. 31, 2024
Schedule of Grant Date Fair Value of Options Granted [Line Items]
Expected volatility	123.00%
Expected term	5 years
Dividend rate	0.00%
Minimum [Member]
Schedule of Grant Date Fair Value of Options Granted [Line Items]
Risk free rate	3.80%
Maximum [Member]
Schedule of Grant Date Fair Value of Options Granted [Line Items]
Risk free rate	4.03%

Other Current Assets

3 Months Ended

Mar. 31, 2024

Other Current Assets [Abstract]

OTHER CURRENT ASSETS

NOTE 2 – OTHER CURRENT ASSETS

Other current assets consisted of the following at March 31, 2024 (unaudited) and December 31, 2023:

	March 31,		December 31,
	2024		2023

Prepaid insurance	$	73,797	$	184,492
Prepaid third party services		411,801		291,512
	$	485,598	$	476,004

Basis of Presentation (Details) - USD ($)	3 Months Ended
Basis of Presentation (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Basis of Presentation [Abstract]
Accumulated deficit	$ (162,588,112)		$ (159,530,535)
Revenue from continuing operations	(160,000)
Loss from operation	(2,900,000)
Net loss from continuing operations	(3,057,577)	$ (1,781,627)
Reclassification of research and development expenses		$ 19,000
Deferred revenue contract liabilities	308,000		$ 132,000
Remaining performance obligation	4,030,000.00
Deferred revenue	310,000
Other non-cancellable contracted amounts	$ 3,730,000
Percentage of remaining performance obligation	40.00%

Intangible Assets, Net (Other than Goodwill) (Tables)

3 Months Ended

Mar. 31, 2024

Intangible Assets, Net (Other than Goodwill) [Abstract]

Schedule of Intangible Assets

The following is a summary of activity related to intangible assets for the three months ended March 31, 2024 (unaudited):

	Acquired and
	Developed
	Software			Patents			Total

Useful Lives	5 Years			10 Years

Carrying Value at December 31, 2023	$	212,798		$	114,203		$	327,001
Amortization		(39,293	)		(4,115	)		(43,408	)
Carrying Value at March 31, 2024	$	173,505		$	110,088		$	283,593

The following is a summary of intangible assets as of March 31, 2024 (unaudited):

	Acquired and
	Developed
	Software			Patents			Total
Cost	$	1,734,662		$	164,614		$	1,899,276
Accumulated amortization		(1,561,157	)		(54,526	)		(1,615,683	)
Carrying Value at March 31, 2024	$	173,505		$	110,088		$	283,593

Schedule of Future Amortization of Intangible Assets

Future expected amortization of intangible assets is as follows:

2024 (Remainder of the Year)	$	130,224
2025		69,328
2026		19,230
2027		16,461
2028		16,461
Thereafter		31,889
	$	283,593

Stockholders' Equity (Details) - USD ($)	3 Months Ended
Stockholders' Equity (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 26, 2023	Dec. 31, 2022
Stockholders' Equity [Line items]
Common stock, shares issued	9,450,220		9,450,220	7,874,962
Common stock, shares outstanding	9,450,220		9,450,220	7,874,962
Common stock, shares authorized	250,000,000		250,000,000
Exercise price (in Dollars per share)	$ 9.38
Warrants [Member]
Stockholders' Equity [Line items]
Common stock, warrant	598,267
Warrant exercise price (in Dollars per share)	$ 11.89
Maturity term of warrant	3 years 255 days
Convertible Notes [Member]
Stockholders' Equity [Line items]
Common stock, shares authorized		68,186
Accrued interest (in Dollars)		$ 222,000
Revision of Prior Period, Adjustment [Member]
Stockholders' Equity [Line items]
Common stock, shares issued				62,816,330
Common stock, shares outstanding				62,816,330
Common Stock [Member]
Stockholders' Equity [Line items]
Common stock, shares issued
Common stock, shares outstanding	9,450,220	3,247,975	9,450,220		3,179,789
Stock Options [Member]
Stockholders' Equity [Line items]
Common stock, warrant	100,000
Stock option based compensation expense (in Dollars)	$ 720,000
Unrecognized stock option based compensation expense (in Dollars)	$ 2,600,000
Stock Options [Member] \| Minimum [Member]
Stockholders' Equity [Line items]
Exercise price (in Dollars per share)	$ 9.05
Stock Options [Member] \| Maximum [Member]
Stockholders' Equity [Line items]
Exercise price (in Dollars per share)	$ 9.61
Mr. Joe Trelin [Member] \| Stock Options [Member]
Stockholders' Equity [Line items]
Sale of stock	6,511
Stock price per share (in Dollars per share)	$ 5.48

Accounts Payable and Accrued Expenses

3 Months Ended

Mar. 31, 2024

Accounts Payable and Accrued Expenses [Abstract]

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consisted of the following as of March 31, 2024 (unaudited) and December 31, 2023:

	March 31,		December 31,
	2024		2023

Trade payables	$	239,376	$	339,832
Accrued payroll and related obligations		412,965		707,317
Other accrued expenses		253,903		361,816
	$	906,244	$	1,408,965

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues, net	$ 157,378	$ 37,856
Operating Expenses:
General and administrative	2,062,361	822,755
Research and development	1,204,968	120,638
Depreciation and amortization	43,408	76,017
Total operating expenses	3,310,737	1,019,410
Loss from continuing operations	(3,153,359)	(981,554)
Other Income (Expense):
Interest expense, net	(13,138)	(800,073)
Interest income	108,920
Other income (expense), net	95,782	(800,073)
Loss from continuing operations before income taxes	(3,057,577)	(1,781,627)
Income tax expense
Loss from continuing operations	(3,057,577)	(1,781,627)
Loss from discontinued operations		(2,255)
Net loss	$ (3,057,577)	$ (1,783,881)
Net Loss Per Share - Basic and Diluted
Continuing operations, Basic (in Dollars per share)	$ (0.32)	$ (0.56)
Discontinued operations, Basic (in Dollars per share)	$ 0	$ 0
Weighted Average Shares Outstanding - Basic (in Shares)	9,450,220	3,180,538

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2024

Stockholders' Equity [Abstract]

Schedule of Grant Date Fair Value of Options Granted

The Company determined the grant date fair value of options granted for the three months ended March 31, 2024, using the Black Scholes Method, as applicable, with the following assumptions:

Expected volatility		123%
Expected term		5 years
Risk free rate		3.80% – 4.03%
Dividend rate		0.00%

Schedule of Activity Related to Stock Options

Activity related to stock options for the three months ended March 31, 2024 (unaudited), is summarized as follows:

				Weighted		Weighted
				Average		Average		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Shares			Price		Term (Yrs.)		Value

Outstanding at December 31, 2023		1,796,743		$	25.20		6.5	$	3,630,733
Granted		100,000		$	9.38		10.0	$	-
Exercised		-		$	-		-	$	-
Forfeited/cancelled		(15,772	)	$	13.35		4.3	$	-
Outstanding as of March 31, 2024		1,880,971		$	24.23		6.4	$	2,163,663
Exercisable as of March 31, 2024		1,158,568		$	30.57		5.0	$	1,085,676

Schedule of Stock Option Information

The following table summarizes stock option information as of March 31, 2024 (unaudited):

			Weighted
			Average
			Contractual
Exercise Price	Outstanding		Term (Yrs.)		Exercisable

$2.64 – $5.00		354,379		8.8		171,103
$5.01 – $10.00		661,189		9.1		224,949
$10.01 – $15.00		43,703		2.7		43,703
$15.01 – $20.00		252,084		1.5		252,084
$20.01 – $121.28		569,616		4.1		466,729
		1,880,971		6.1		1,158,568

Other Current Assets (Tables)

3 Months Ended

Mar. 31, 2024

Other Current Assets [Abstract]

Schedule of Other Current Assets

Other current assets consisted of the following at March 31, 2024 (unaudited) and December 31, 2023:

	March 31,		December 31,
	2024		2023

Prepaid insurance	$	73,797	$	184,492
Prepaid third party services		411,801		291,512
	$	485,598	$	476,004

Stockholders' Equity (Details) - Schedule of Stock Option Information	3 Months Ended
	Mar. 31, 2024 shares
Schedule of Stock Option Information [Line Items]
Outstanding	1,880,971
Weighted Average Contractual Term (Yrs.)	6 years 1 month 6 days
Exercisable	1,158,568
$2.64 – $5.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	354,379
Weighted Average Contractual Term (Yrs.)	8 years 9 months 18 days
Exercisable	171,103
$5.01 – $10.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	661,189
Weighted Average Contractual Term (Yrs.)	9 years 1 month 6 days
Exercisable	224,949
$10.01 – $15.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	43,703
Weighted Average Contractual Term (Yrs.)	2 years 8 months 12 days
Exercisable	43,703
$15.01 – $20.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	252,084
Weighted Average Contractual Term (Yrs.)	1 year 6 months
Exercisable	252,084
$20.01 – $121.28 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	569,616
Weighted Average Contractual Term (Yrs.)	4 years 1 month 6 days
Exercisable	466,729

Intangible Assets, Net (Other than Goodwill)

3 Months Ended

Mar. 31, 2024

Intangible Assets, Net (Other than Goodwill) [Abstract]

INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the three months ended March 31, 2024 (unaudited):

	Acquired and
	Developed
	Software			Patents			Total

Useful Lives	5 Years			10 Years

Carrying Value at December 31, 2023	$	212,798		$	114,203		$	327,001
Amortization		(39,293	)		(4,115	)		(43,408	)
Carrying Value at March 31, 2024	$	173,505		$	110,088		$	283,593

The following is a summary of intangible assets as of March 31, 2024 (unaudited):

	Acquired and
	Developed
	Software			Patents			Total
Cost	$	1,734,662		$	164,614		$	1,899,276
Accumulated amortization		(1,561,157	)		(54,526	)		(1,615,683	)
Carrying Value at March 31, 2024	$	173,505		$	110,088		$	283,593

Amortization expense totaled approximately $43,000 and $76,000 for the three months ended March 31, 2024, and 2023, respectively.

Future expected amortization of intangible assets is as follows:

2024 (Remainder of the Year)	$	130,224
2025		69,328
2026		19,230
2027		16,461
2028		16,461
Thereafter		31,889
	$	283,593

There was no impairment indicator identified for impairment of the Company’s intangible assets and goodwill as of March 31, 2024.

Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Intangible Assets	3 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Intangible Assets [Line Items]
Carrying Value, Beginning	$ 327,001
Amortization	(43,408)
Carrying Value, Ending	283,593
Cost	1,899,276
Accumulated amortization	$ (1,615,683)
Acquired and Developed Software [Member]
Schedule of Intangible Assets [Line Items]
Useful Lives	5 years
Carrying Value, Beginning	$ 212,798
Amortization	(39,293)
Carrying Value, Ending	173,505
Cost	1,734,662
Accumulated amortization	$ (1,561,157)
Patents [Member]
Schedule of Intangible Assets [Line Items]
Useful Lives	10 years
Carrying Value, Beginning	$ 114,203
Amortization	(4,115)
Carrying Value, Ending	110,088
Cost	164,614
Accumulated amortization	$ (54,526)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2024

Basis of Presentation [Abstract]

Going Concern

Going Concern

Reclassification

Reclassification

Net Loss per Common Share

Net Loss per Common Share

Security	2024		2023

Convertible notes payable		8,277		308,287
Warrants		598,267		153,653
Stock options		1,880,971		993,208
		2,487,515		1,455,148

Revenue Recognition

Revenue Recognition

Remaining Performance Obligations

Remaining Performance Obligations

Deferred Contract Costs

	Deferred
	Contract Costs

Carrying Value at December 31, 2023	$	157,300
Additions		5,850
Amortization		(2,432	)
Carrying Value at March 31, 2024	$	160,718

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 7,226,212	$ 10,177,099
Accounts receivable, net	328,782	91,277
Deferred contract costs	160,718	157,300
Other current assets, net	485,598	476,004
Contract assets	49,713
Total current assets	8,251,023	10,901,680
Intangible Assets, net	283,593	327,001
Goodwill	4,183,232	4,183,232
Total assets	12,717,848	15,411,913
Current Liabilities:
Accounts payable and accrued expenses	906,244	1,408,965
Deferred revenue	307,647	131,628
Commission liability	83,200	124,150
Convertible debt, net	228,539
Total current liabilities	1,525,630	1,664,743
Non-current Liabilities:
Convertible debt, net		224,424
Accrued severance liability	325,000	325,000
Total liabilities	1,850,630	2,214,167
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
Common stock, $0.0001 par value, 250,000,000 shares authorized; 9,450,220 shares issued and outstanding as of March 31, 2024 and December 31, 2023	945	945
Additional paid in capital	173,437,683	172,714,712
Accumulated deficit	(162,588,112)	(159,530,535)
Accumulated comprehensive income	16,702	12,624
Total stockholders’ equity	10,867,218	13,197,746
Total liabilities and stockholders’ equity	$ 12,717,848	$ 15,411,913

Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2024

Basis of Presentation [Abstract]

Schedule of Diluted Loss per Share

The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three months ended March 31, 2024 and 2023 because their effect was antidilutive:

Security	2024		2023

Convertible notes payable		8,277		308,287
Warrants		598,267		153,653
Stock options		1,880,971		993,208
		2,487,515		1,455,148

Schedule of Deferred Contract Cost Activity

The following table summarizes deferred contract cost activity for the three months ended March 31, 2024:

	Deferred
	Contract Costs

Carrying Value at December 31, 2023	$	157,300
Additions		5,850
Amortization		(2,432	)
Carrying Value at March 31, 2024	$	160,718

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Continuing operations, Diluted	$ (0.32)	$ (0.56)
Discontinued operations, Diluted	$ 0.00	$ 0.00
Weighted Average Shares Outstanding – Diluted (in Shares)	9,450,220	3,180,538

- Definition

The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

+ Details

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 10, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Information [Line Items]
Entity Registrant Name	authID Inc.
Entity Central Index Key	0001534154
Entity File Number	001-40747
Entity Tax Identification Number	46-2069547
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	1580 North Logan Street
Entity Address, Address Line Two	Suite 660, Unit 51767
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80203
Entity Phone Fax Numbers [Line Items]
City Area Code	516
Local Phone Number	274-8700
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock par value $0.0001 per share
Trading Symbol	AUID
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		9,450,220

Other Current Assets (Details) - Schedule of Other Current Assets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Other Current Assets [Abstract]
Prepaid insurance	$ 73,797	$ 184,492
Prepaid third party services	411,801	291,512
Total other current assets	$ 485,598	$ 476,004

Insider Trading Arrangements

3 Months Ended

Mar. 31, 2024

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

Retirement of Joseph Trelin and Appointment of Kunal Metha

On February 15, 2024, Mr. Joe Trelin tendered his resignation as Chairman and a Director of the Company, effective immediately. On February 20, 2024, the Board of Directors of the Company accepted his resignation and agreed to vest the unvested portion of an option granted to Mr. Trelin June 28, 2023, amounting to 6,511 shares.

On March 25, 2024, Kunal Mehta was appointed as an independent member of the Board of Directors of the Company. Mr. Mehta entered into a letter agreement with the Company pursuant to which, in addition to other compensation, he will be granted options to purchase common stock on the third trading day after the announcement of the Company’s results for the first quarter of 2024.

Equity Grant Policy

Recognizing the importance of adhering to appropriate practices and procedures when granting equity awards, on April 19, 2024, the Board of Directors adopted the Policy on Granting Equity Awards. Under this policy, the Compensation Committee of the Board of Directors may grant equity awards. The Compensation Committee may from time to time grant limited authority to the CEO to offer awards to new hires subject to Compensation Committee ratification. The policy established the following procedures for the Company to issue equity awards:

●

Equity award grants to existing employees shall be made on a date when the Company’s insider trading window is “open” (i.e., when the Company is not in possession of material non-public information), and which is at least three business days after the most recent release of the Company’s quarterly or annual earnings, or Form 8-K Current Report that discloses material non-public information.

●

With respect to grants made to named executive officers, the Company shall not grant and/or price of stock options or other incentive securities under any securities-based compensation arrangement of the Company during the period beginning four (4) business days before and ending one (1) business day after the filing by the Company of a Form 10-Q Quarterly Report, Form 10-K Annual Report or Form 8-K Current Report that discloses material non-public information.

●

Grants of stock options to new hires (other than to new hires who will be Section 16 officers), or for promotions, retention or other special purposes will be described as subject to the approval of the Compensation Committee at its next scheduled meeting and the grant date of such stock options, if approved by the Compensation Committee, shall be the date of such meeting.

●

Annual grants of equity awards to members of the Board of Directors shall be effective within three business days after the date of the Annual Stockholders Meeting at which such Director is elected or re-elected.

We plan to monitor and periodically review our equity grant policy to ensure compliance with plan rules and applicable law.

Rule 10b5-1 Arrangement Adopted

false

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Accounts Payable and Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2024

Accounts Payable and Accrued Expenses [Abstract]

Schedule of Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following as of March 31, 2024 (unaudited) and December 31, 2023:

	March 31,		December 31,
	2024		2023

Trade payables	$	239,376	$	339,832
Accrued payroll and related obligations		412,965		707,317
Other accrued expenses		253,903		361,816
	$	906,244	$	1,408,965

Related Party Transactions (Details) - USD ($)	Jun. 28, 2023	Mar. 31, 2024
Related Party Transaction [Line Items]
Prepaid expenses		$ 163,000
Board of Directors [Member]
Related Party Transaction [Line Items]
Unvested option granted	6,511

Basis of Presentation (Details) - Schedule of Deferred Contract Cost Activity	3 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Deferred Contract Cost Activity [Abstract]
Carrying Value at December 31, 2023	$ 157,300
Additions	5,850
Amortization	(2,432)
Carrying Value at March 31, 2024	$ 160,718

Pay vs Performance Disclosure - USD ($)	3 Months Ended
Pay vs Performance Disclosure - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (3,057,577)	$ (1,783,881)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Stockholders' Equity (Details) - Schedule of Activity Related to Stock Options - USD ($)		3 Months Ended
	Dec. 31, 2023	Mar. 31, 2024
Schedule of Activity Related to Stock Options [Abstract]
Number of Shares, Ending Outstanding	1,796,743	1,880,971
Weighted Average Exercise Price, Ending Outstanding	$ 25.2	$ 24.23
Weighted Average Contractual Life, Ending Outstanding	6 years 6 months	6 years 4 months 24 days
Aggregate Intrinsic Value, Ending Outstanding	$ 3,630,733	$ 2,163,663
Number of Shares, Exercisable		1,158,568
Weighted Average Exercise Price, Exercisable		$ 30.57
Weighted Average Contractual Life, Exercisable		5 years
Aggregate Intrinsic Value, Exercisable		$ 1,085,676
Number of Shares, Granted		100,000
Weighted Average Exercise Price, Granted		$ 9.38
Weighted Average Contractual Life, Granted		10 years
Aggregate Intrinsic Value, Granted
Number of Shares, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Contractual Life, Exercised
Aggregate Intrinsic Value, Exercised
Number of Shares, Forfeited/cancelled		(15,772)
Weighted Average Exercise Price, Forfeited/cancelled		$ 13.35
Weighted Average Contractual Life, Forfeited/cancelled		4 years 3 months 18 days
Aggregate Intrinsic Value, Forfeited/cancelled

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	9,450,220	9,450,220
Common stock, shares outstanding	9,450,220	9,450,220

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2022	$ 318	$ 140,257,448	$ (140,130,159)	$ 155,929	$ 283,536
Balances (in Shares) at Dec. 31, 2022	3,179,789
Stock-based compensation		(2,598,592)			(2,598,592)
Shares issued in lieu of interest	$ 7	222,420			222,427
Shares issued in lieu of interest (in Shares)	68,186
Net loss			(1,783,881)		(1,783,881)
Foreign currency translation				(24,066)	(24,066)
Balances at Mar. 31, 2023	$ 325	137,881,276	(141,914,040)	131,863	(3,900,576)
Balances (in Shares) at Mar. 31, 2023	3,247,975
Balances at Dec. 31, 2023	$ 945	172,714,712	(159,530,535)	12,624	$ 13,197,746
Balances (in Shares) at Dec. 31, 2023	9,450,220				9,450,220
Stock-based compensation		722,971			$ 722,971
Net loss			(3,057,577)		(3,057,577)
Foreign currency translation				4,078	4,078
Balances at Mar. 31, 2024	$ 945	$ 173,437,683	$ (162,588,112)	$ 16,702	$ 10,867,218
Balances (in Shares) at Mar. 31, 2024	9,450,220				9,450,220

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2

+ Details

Subsequent Event

3 Months Ended

Mar. 31, 2024

Subsequent Event [Abstract]

SUBSEQUENT EVENT

NOTE 8 – SUBSEQUENT EVENT

Management of the Company has performed a review of all events and transactions occurring after the condensed consolidated balance sheet date and determined there were no events or transactions requiring adjustment to or disclosure in the accompanying condensed consolidated financial statements.

Commitments and Contingencies (Details) - USD ($)	3 Months Ended
Commitments and Contingencies (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Commitments and Contingencies [Line Items]
General and administrative	$ 1,000	$ 5,000

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details